Literature DB >> 2544998

Human diabetes associated with a mutation in the tyrosine kinase domain of the insulin receptor.

M Odawara1, T Kadowaki, R Yamamoto, Y Shibasaki, K Tobe, D Accili, C Bevins, Y Mikami, N Matsuura, Y Akanuma.   

Abstract

Insulin receptor complementary DNA has been cloned from an insulin-resistant individual whose receptors have impaired tyrosine protein kinase activity. One of this individual's alleles has a mutation in which valine is substituted for Gly996, the third glycine in the conserved Gly-X-Gly-X-X-Gly motif in the putative binding site fo adenosine triphosphate. Expression of the mutant receptor by transfection into Chinese hamster ovary cells confirmed that the mutation impairs tyrosine kinase activity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2544998     DOI: 10.1126/science.2544998

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  42 in total

Review 1.  Diabetes mellitus.

Authors:  A B Johnson; R Taylor
Journal:  Postgrad Med J       Date:  1990-12       Impact factor: 2.401

2.  Defects in insulin binding and receptor kinase in cells from a woman with type A insulin resistance and from her family.

Authors:  Y Suzuki; N Hashimoto; F Shimada; M Taira; M Mimura; O Nozaki; M Tawata; T Onaya; H Makino; S Yoshida
Journal:  Diabetologia       Date:  1991-02       Impact factor: 10.122

3.  Abnormal messenger ribonucleic acid (mRNA) transcribed from a mutant insulin receptor gene in a patient with type A insulin resistance.

Authors:  F Shimada; Y Suzuki; M Taira; N Hashimoto; O Nozaki; H Makino; S Yoshida
Journal:  Diabetologia       Date:  1992-07       Impact factor: 10.122

4.  Genetic and structural variation in the gastric cancer kinome revealed through targeted deep sequencing.

Authors:  Zhi Jiang Zang; Choon Kiat Ong; Ioana Cutcutache; Willie Yu; Shen Li Zhang; Dachuan Huang; Lian Dee Ler; Karl Dykema; Anna Gan; Jiong Tao; Siyu Lim; Yujing Liu; P Andrew Futreal; Heike Grabsch; Kyle A Furge; Liang Kee Goh; Steve Rozen; Bin Tean Teh; Patrick Tan
Journal:  Cancer Res       Date:  2010-11-19       Impact factor: 12.701

5.  Transdominant inhibition of tyrosine kinase activity in mutant insulin/insulin-like growth factor I hybrid receptors.

Authors:  J L Treadway; B D Morrison; M A Soos; K Siddle; J Olefsky; A Ullrich; D A McClain; J E Pessin
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

Review 6.  Structural basis of protein kinase C isoform function.

Authors:  Susan F Steinberg
Journal:  Physiol Rev       Date:  2008-10       Impact factor: 37.312

Review 7.  Insulin resistance due to mutations of the insulin receptor gene: an overview.

Authors:  D Accili; A Cama; F Barbetti; H Kadowaki; T Kadowaki; S I Taylor
Journal:  J Endocrinol Invest       Date:  1992-12       Impact factor: 4.256

8.  Congenital disease SNPs target lineage specific structural elements in protein kinases.

Authors:  Ali Torkamani; Natarajan Kannan; Susan S Taylor; Nicholas J Schork
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-25       Impact factor: 11.205

9.  Are MELAS and diabetes mellitus caused solely by the same mutation at np 3243 of the mitochondrial gene?

Authors:  M Odawara; K Yamashita
Journal:  Diabetologia       Date:  1995-12       Impact factor: 10.122

10.  The association of phosphoinositide 3-kinase enhancer A with hepatic insulin receptor enhances its kinase activity.

Authors:  Chi Bun Chan; Xia Liu; Kunyan He; Qi Qi; Dae Y Jung; Jason K Kim; Keqiang Ye
Journal:  EMBO Rep       Date:  2011-07-01       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.